Reforms may undermine NHS cost savings, say MPs

April 27, 2011
NHS, NHS reform, Public Accounts Comittee

Radical reforms to the NHS in England could undermine the drive to save ยฃ20 billion over the next four years. …

Open Health recruits new associate partner

April 27, 2011
Medical Communications appointment, medical communications

Margot Rozga has joined new med comms agency Open Health as an associate partner. The move to the Marlow, UK-based …

Caribbean tunicate Ecteinascidia turbinata

NICE gives final no to PharmaMar’s Yondelis

April 27, 2011
Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

A lack of evidence and an unconvincing patient access scheme has seen PharmaMar fail to win NICE backing for its …

CME Spotlight: education providers and pharma need guidance

April 27, 2011
Medical Communications CME, CME Spotlight

Transplanting the testes and pituitary gland of a social outcast into a dog is the theme of a new opera …

Boehringer Ingelheim

Boehringer begins late-stage hep C trial

April 27, 2011
Research and Development BI 201335, Boehringer Ingelheim, hepatitis C

Boehringer Ingelheim has begun enrolling patients in North America for a phase III trial of its chronic hepatitis C virus …

Bayer UK Twitter Levitra

Digital Pharma: Bayer UK’s Twitter slip-up

April 26, 2011
Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA, Twitter, medicial communications

There seems to be some confusion at Bayer UK over what communications can be sent over Twitter. The company is …

Bayer defends Yasmin against BMJ studies

April 26, 2011
Sales and Marketing Bayer, Yasmin, contraception

Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …

Merck & Co kicks off expansion of Durham vaccines facility

April 26, 2011
Manufacturing and Production Merck & Co, manufacturing and production, vaccines

Merck & Co is expanding its vaccines facility in North Carolina, USA, bucking a recent trend at the manufacturer for …

Pfizer

Deaths reported in Pfizer arthritis trial

April 26, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Four deaths have been reported in a late-stage study of Pfizerโ€™s arthritis drug tofacitinib. Three of the deaths are thought …

Anglo-Chinese joint venture makes first API batches

April 26, 2011
Manufacturing and Production China, Hebei Aoxing Pharmaceutical, Macfarlan Smith, manufacturing and production

China’s Hebei Aoxing Pharmaceutical has passed a major milestone in its joint venture with process technology specialist Macfarlan Smith to …

Sten Westerberg joins BioInvent

April 26, 2011
Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …

William Weldon

Top 5 reasons for a Class I product recall

April 21, 2011
Manufacturing and Production Johnson & Johnson, product recalls

Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …

Digital Pharma: Boehringer UK tweets politicians with afib message

April 21, 2011
Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications

Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …

WPP launches UK healthcare digital division

April 21, 2011
Medical Communications Ogilvy, Ogilvy Healthworld UK, OgilvyHealthPR, WPP, medical communications, ogilvy healthworld advertising

Communications giant WPP has merged the digital activities of two media brands to launch a new entity in the UK, …

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011
Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

Report sounds off-label prescribing warning

April 21, 2011
Sales and Marketing EAASM, off label

A pharma-backed group has warned that some โ€˜off-labelโ€™ prescribing is dangerous for patients. A report by the European Alliance for …

Trevor Smith to lead Takeda in Europe

April 21, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …

Saving billions through ‘innovation’ – can the NHS pull it off?

April 21, 2011
NHS reforms

Innovation is not a concept immediately associated with the UKโ€™s national health service, but is now being promoted by the …

Procurement pitfalls and hurdles of lab equipment for clinical trials

April 20, 2011
Research and Development clinical trials, medical equipment, mesm, procurement

 Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …

The Gateway to Local Adoption Series

Latest content